Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 43Leukemia 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Leukemia, Myeloid, Acute 32Lymphoma 30Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Mantle-Cell 26Lymphoma, Follicular 26Leukemia, Myeloid, Chronic-Phase 26Lymphoma, Non-Hodgkin 25Leukemia, Myeloid, Accelerated Phase 24Lymphoma, B-Cell, Marginal Zone 23Lymphoma, Large B-Cell, Diffuse 22Hodgkin Disease 22Burkitt Lymphoma 22Anemia, Refractory, with Excess of Blasts 22Multiple Myeloma 21Congenital Abnormalities 19Myeloproliferative Disorders 18Lymphoma, Large-Cell, Immunoblastic 18Blast Crisis 18Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 16Recurrence 15Neoplasms, Plasma Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Biphenotypic, Acute 13Primary Myelofibrosis 12Myelodysplastic-Myeloproliferative Diseases 12

Interventions

decitabine and cedazuridine drug combination 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Allogeneic Stem Cell Transplantation × Cord Blood Stem Cell Transplantation × Clear all
NCT01092026 2023-12-06

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

Universitair Ziekenhuis Brussel

Phase NA Completed
11 enrolled

Allogeneic Stem Cell Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡